How is the Theratechnologies Inc. today?

The Theratechnologies Inc. today is trading in the down by -0.38% at 2.61.

What is Theratechnologies Inc. Annual Revenue?

Theratechnologies Inc. Annual Revenue rose 5.02%, in the last year to $85.87 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Theratechnologies Inc. Annual Net Profit?

Theratechnologies Inc. Annual Net Profit rose 65.33% in the last year to $8.31 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is Theratechnologies Inc. Price to Earning Ratio?

Theratechnologies Inc. Price to Earning Ratio is -32.37, which is negative.

What is Theratechnologies Inc. Stock Price?

Theratechnologies Inc. Stock Price rose 99.24% and outperformed its sector by 90.38% in the past year.

What is Theratechnologies Inc. Quarterly Revenue?

Theratechnologies Inc. Quarterly Revenue rose 17.23% YoY to $19.05 M. Its sector's average revenue growth YoY for the quarter was 3.1%.

What is Theratechnologies Inc. Quarterly Net profit?

Theratechnologies Inc. Quarterly Net profit rose 102.61% YoY to $0.12 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is Theratechnologies Inc. Mutual Fund Holding?

Theratechnologies Inc. Mutual Fund Holding increased by 0.05% in the last quarter to 0.13.

What is Theratechnologies Inc. Interest Coverage Ratio?

Theratechnologies Inc. Interest Coverage Ratio is 0.4, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Theratechnologies Inc. Institutional Holding?

Theratechnologies Inc. Institutional Holding decreased by 1.46% in the last quarter to 29.07.

Theratechnologies Inc. XNAS: THTX

Theratechnologies Inc. Live Share Price Today, Share Analysis and Chart

Name: Theratechnologies Inc.: Is Infosys Ltd. worth buying?
Item: Theratechnologies Inc.
Rating: 2.20558325
Author: Trendlyne DVM scores

about

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United S...

2.61 -0.01 (-0.38%)

133.04% Gain from 52W Low

92,717 XNAS Volume

XNAS 16 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

15.8 / 100

Technically Bullish

72.4 / 100

4

1Yr Price target upside is 49%

2 analysts

Theratechnologies Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Theratechnologies Inc. FAQ

How is Theratechnologies Inc. today?

Theratechnologies Inc. today is trading in the red, and is down by -0.38% at 2.61.

How has Theratechnologies Inc. performed historically?

Theratechnologies Inc. is currently trading down -0.38% on an intraday basis. In the past week the stock fell -0.38%. stock has been up 49.14% in the past quarter and rose 99.24% in the past year. You can view this in the overview section.